(Date:11/6/2009)... 6 Chimerix, Inc., a biopharmaceut...therapeutics to address life-threatening diseases,...ny,s lead antiviral compound, CMX001, to the World...ecurity Initiative (GHSI). CMX001 is a broad-spec...ment of smallpox, as well as other serious viral i...
(Date:11/6/2009)...NexBio Inc., in collaboration with scientists at t...), St. Louis University, and the University of Hon...icles in the peer-reviewed journal PLoS ONE. Thes...se ® ) may play a potentially important role ...nfluenza A(H1N1) and drug-resistant influenza. ,...
(Date:11/6/2009)... -- , - Trial Will Compare NXL103 With Le...lti-Resistant Staphylococcus Aureus (MRSA) Infecti...l company focused on the discovery and,development...nificant global,problem of microbial resistance, a...terial NXL103 (flopristin/linopristin), has starte...
Breaking Medicine Technology:Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Exploring standards to advance microbial genomics 9201 1Exploring standards to advance microbial genomics 9201 2Exploring standards to advance microbial genomics 9201 3Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal 28R 29 Vet a New Chemotherapeutic Agent for Dogs 51323 1Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal 28R 29 Vet a New Chemotherapeutic Agent for Dogs 51323 2Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal 28R 29 Vet a New Chemotherapeutic Agent for Dogs 51323 3Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal 28R 29 Vet a New Chemotherapeutic Agent for Dogs 51323 4China Biotics Inc Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results 12968 1China Biotics Inc Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results 12968 2...s; 11 Breast Cancer Studies; 9 Targeted,Agent Stud...all/ -- Lilly,Oncology will unveil 76 studies at t...Clinical Oncology (ASCO) in Chicago, Ill. from,Jun...ta on,GEMZAR(R) (gemcitabine HCl for injection), A...in, an investigational, oral, targeted,therapy. Th...
...ia--(BUSINESS WIRE)--May 23, 2007 -,ProtoKinetix I...studies conducted by ITTEC Stem, Inc. at the Unive...AAGP(TM) in the cryopreservation,process for stem ...ecule in the rapidly expanding stem cell industry....on human embryonic stem cells., Using standard cry...
Other Medicine Technology:Making Science Personal: Lilly Oncology to Unveil 76 Studies at,ASCO 2007 2ProtoKinetix's AAGP Dramatically Increases Recovery Rate of,Cryopreserved Stem Cells 2(Date:11/8/2009)...are Reform Bill ,, Critical legislation would...ricans ,, CHICAGO, Nov. 7 /PRNewswire-USNewswi...atives passed by a vote of 220-215, critical healt...dicare for seniors and end discrimination by insur...ut of affordable health coverage. ,, The Affo...
(Date:11/7/2009)...re/ -- Karen Ignagni, President and CEO of America...lowing statement today on House passage of H.R. 39...sive health care reform, and we have contributed t... of how health insurance is provided. Earlier this...n of pre-existing condition exclusions, no longer ...
(Date:11/7/2009)...ok (GA), Louis J. Goodman (TX), Palmer P. Jones (N...ov. 7 The American Medi... society executive leaders with achievement awards...als of the medical profession. The awards were pre...ing in Houston. ,, (Logo: http://www.newscom...
(Date:11/7/2009)...ponsibility to vigorously oppose abortion in healt...INGTON, Nov. 7 Ameri... following statement on the news that Cardinal Jus...ordable Health Care for America Act (H.R. 3962), p... abortion is voted upon. ,, "Our Catholic bish...
(Date:11/7/2009)...ty of America (PRSA) will bestow the distinguished...e president of Brand Strategy, Communications and ... PRSA,s 2009 International Conference in San Diego...llows is one of the profession,s highest individua...PRSA, and 2009 chair of the College of Fellows. "I...
Breaking Medicine News(10 mins):Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors Medical Society Executives 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3...LIN, N.J., April 21 Pharmos Corporation (Pink S... a private placement of common stock and warrants....ares of common stock and warrants exercisable for ...year term, is $0.12 per share. , , The three purc...
...Los Angeles Exposition Park , , LOS ANGE...Dimes premier fundraising event that benefits all ... to survive and thrive. 11,000 walkers are expecte...les, CA this Saturday, April 25. , , (Logo: http...
... YORK, April 21 Carl Icahn announced today that h... Jr., Chairman of the Board and James Wilson, Lead...nc. (Nasdaq: AMLN ) concerning recent discussion...irman of the Board, James Wilson, Lead Independ...
... YORK, April 21 Immtech Pharmaceuticals, Inc. (NY...is reorganizing its R&D operations. This restr...nities based on the Company,s ongoing discovery pr...l Development & Chief Medical Officer is being...
...ng contradicts belief that process favors people i...hDay News) -- People with kidney failure who live ...t a kidney transplant than people in urban areas, ...d 2007. After about two years on the list, 122,785...
... finds fewer complications with electrophysiologis...-- Chances are you,ve never heard of electrophysio...now about if you are one of the 100,000 or so Amer...rly. And the incidence of in-hospital complication...
Other Medicine News:Health News:Pharmos Completes Private Placement - Raises $1.8 Million 2Health News:Pharmos Completes Private Placement - Raises $1.8 Million 3Health News:Farmers Insurance Joins March of Dimes March for Babies April 25, 2009 2Health News:Icahn Responds to Cook and Wilson 2Health News:Icahn Responds to Cook and Wilson 3Health News:Icahn Responds to Cook and Wilson 4Health News:Immtech to Reorganize Research and Development Operations 2Health News:Immtech to Reorganize Research and Development Operations 3Health News:Distance No Bar to Kidney Transplants in Remote Areas 2Health News:Doctor's Training Affects Defibrillator Implant Results 2Health News:Doctor's Training Affects Defibrillator Implant Results 3Hemmingway
Kerpel
Endocrette Endocervical Curette
London Endocervical Curette
Medicine Products: